Abbott Laboratories Total Assets 2010-2025 | ABT
Abbott Laboratories total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Abbott Laboratories total assets for the quarter ending March 31, 2025 were $81.448B, a 12.39% increase year-over-year.
- Abbott Laboratories total assets for 2024 were $81.414B, a 11.2% increase from 2023.
- Abbott Laboratories total assets for 2023 were $73.214B, a 1.64% decline from 2022.
- Abbott Laboratories total assets for 2022 were $74.438B, a 1.01% decline from 2021.
| Abbott Laboratories Annual Total Assets (Millions of US $) |
|
|---|---|
| 2024 | $81,414 |
| 2023 | $73,214 |
| 2022 | $74,438 |
| 2021 | $75,196 |
| 2020 | $72,548 |
| 2019 | $67,887 |
| 2018 | $67,173 |
| 2017 | $76,250 |
| 2016 | $52,666 |
| 2015 | $41,247 |
| 2014 | $41,207 |
| 2013 | $42,953 |
| 2012 | $67,235 |
| 2011 | $60,277 |
| 2010 | $60,574 |
| 2009 | $52,582 |
| Abbott Laboratories Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $81,448 |
| 2024-12-31 | $81,414 |
| 2024-09-30 | $74,356 |
| 2024-06-30 | $73,017 |
| 2024-03-31 | $72,467 |
| 2023-12-31 | $73,214 |
| 2023-09-30 | $72,090 |
| 2023-06-30 | $73,354 |
| 2023-03-31 | $73,794 |
| 2022-12-31 | $74,438 |
| 2022-09-30 | $72,801 |
| 2022-06-30 | $74,202 |
| 2022-03-31 | $74,007 |
| 2021-12-31 | $75,196 |
| 2021-09-30 | $73,795 |
| 2021-06-30 | $73,269 |
| 2021-03-31 | $72,785 |
| 2020-12-31 | $72,548 |
| 2020-09-30 | $69,043 |
| 2020-06-30 | $68,776 |
| 2020-03-31 | $66,777 |
| 2019-12-31 | $67,887 |
| 2019-09-30 | $68,539 |
| 2019-06-30 | $68,427 |
| 2019-03-31 | $67,610 |
| 2018-12-31 | $67,173 |
| 2018-09-30 | $71,637 |
| 2018-06-30 | $68,415 |
| 2018-03-31 | $70,908 |
| 2017-12-31 | $76,250 |
| 2017-09-30 | $72,248 |
| 2017-06-30 | $71,151 |
| 2017-03-31 | $70,887 |
| 2016-12-31 | $52,666 |
| 2016-09-30 | $39,497 |
| 2016-06-30 | $39,831 |
| 2016-03-31 | $39,637 |
| 2015-12-31 | $41,247 |
| 2015-09-30 | $41,725 |
| 2015-06-30 | $44,125 |
| 2015-03-31 | $43,095 |
| 2014-12-31 | $41,207 |
| 2014-09-30 | $42,514 |
| 2014-06-30 | $41,475 |
| 2014-03-31 | $41,662 |
| 2013-12-31 | $42,953 |
| 2013-09-30 | $44,132 |
| 2013-06-30 | $42,903 |
| 2013-03-31 | $42,687 |
| 2012-12-31 | $67,235 |
| 2012-09-30 | $63,258 |
| 2012-06-30 | $61,860 |
| 2012-03-31 | $62,416 |
| 2011-12-31 | $60,277 |
| 2011-09-30 | $59,628 |
| 2011-06-30 | $62,004 |
| 2011-03-31 | $61,651 |
| 2010-12-31 | $60,574 |
| 2010-09-30 | $57,374 |
| 2010-06-30 | $53,381 |
| 2010-03-31 | $53,359 |
| 2009-12-31 | $52,582 |
| 2009-09-30 | $49,847 |
| 2009-06-30 | $47,630 |
| 2009-03-31 | $45,438 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $235.957B | $41.950B |
| Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boston Scientific (BSX) | United States | $147.560B | 36.94 |
| Stryker (SYK) | United States | $144.011B | 30.11 |
| EssilorLuxottica (ESLOY) | France | $128.708B | 0.00 |
| Medtronic (MDT) | Ireland | $111.928B | 15.87 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.371B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.904B | 27.87 |
| ResMed (RMD) | United States | $36.560B | 27.46 |
| Agilent Technologies (A) | United States | $33.258B | 21.68 |
| GE HealthCare Technologies (GEHC) | United States | $33.082B | 15.71 |
| Terumo (TRUMY) | Japan | $26.680B | 34.65 |
| Insulet (PODD) | United States | $21.438B | 84.15 |
| Koninklijke Philips (PHG) | Netherlands | $21.384B | 15.37 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.060B | 11.60 |
| Baxter (BAX) | United States | $15.713B | 11.73 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.872B | 0.00 |
| Demant (WILYY) | Denmark | $9.377B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.175B | 21.49 |
| Lantheus Holdings (LNTH) | United States | $5.385B | 13.58 |
| Prestige Consumer Healthcare (PBH) | United States | $4.149B | 18.54 |
| Perrigo (PRGO) | Ireland | $3.664B | 9.29 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.367B | 15.34 |
| ICU Medical (ICUI) | United States | $3.250B | 23.96 |
| Envista Holdings (NVST) | United States | $3.127B | 25.99 |
| GN Store Nord (GNNDY) | Denmark | $2.263B | 18.74 |
| QuidelOrtho (QDEL) | United States | $1.954B | 13.44 |
| LeMaitre Vascular (LMAT) | United States | $1.833B | 40.97 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Acuren (TIC) | United States | $1.357B | 0.00 |
| Neogen (NEOG) | United States | $1.200B | 15.36 |
| AdaptHealth (AHCO) | United States | $1.161B | 11.78 |
| Green Thumb Industries (GTBIF) | United States | $1.048B | 23.58 |
| BioLife Solutions (BLFS) | United States | $1.046B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.970B | 12.40 |
| Kestra Medical Technologies (KMTS) | United States | $0.904B | 0.00 |
| InMode (INMD) | Israel | $0.844B | 8.51 |
| Evolus (EOLS) | United States | $0.640B | 0.00 |
| CeriBell (CBLL) | United States | $0.624B | 0.00 |
| Owens & Minor (OMI) | United States | $0.602B | 4.99 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.542B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.538B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.524B | 0.00 |
| Valneva SE (VALN) | France | $0.510B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.407B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.337B | 12.41 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.329B | 58.50 |
| Canopy Growth (CGC) | Canada | $0.272B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.263B | 22.17 |
| Sanara MedTech (SMTI) | United States | $0.256B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.254B | 0.00 |
| ZimVie (ZIMV) | United States | $0.253B | 11.52 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.245B | 0.00 |
| Quanterix (QTRX) | United States | $0.235B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.207B | 5.82 |
| Brainsway (BWAY) | Israel | $0.206B | 54.50 |
| Omeros (OMER) | United States | $0.199B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
| Organigram Global (OGI) | Canada | $0.187B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.179B | 14.59 |
| Verano Holdings (VRNOF) | United States | $0.174B | 0.00 |
| Exagen (XGN) | United States | $0.152B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.140B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 0.00 |
| Jin Medical (ZJYL) | China | $0.107B | 0.00 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.64 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.087B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Agape ATP (ATPC) | $0.084B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.075B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.29 |
| United-Guardian (UG) | United States | $0.037B | 12.90 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.019B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Safety Shot (SHOT) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| INLIF (INLF) | $0.012B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |